Endogena Therapeutics
PrivateLast Round
Series A
Extension
Dec 13, 2021
Total Funding Raised
$29M
Company Overview
Endogena Therapeutics is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs, with a focus on degenerative diseases of the eye.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endogena Therapeutics Comparables
Compare Endogena Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Centenara Labs | 94% | |
| jCyte, Inc. | 87% | |
| Nacuity Pharmaceuticals, Inc. | 83% |
Endogena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 13, 2021 | ||||
| Series A | Jan 26, 2021 |
Endogena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DEFTA Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors increased 41% MoM.
- Dec 13, 2021
$21M round led by Centenara Labs.
Endogena Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endogena Therapeutics's valuation, stock price, and market status.
Is Endogena Therapeutics a public or private company?
Endogena Therapeutics is a private company.
What is the current stock price of Endogena Therapeutics?
Endogena Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Endogena Therapeutics worth (valuation)?
Valuation information for Endogena Therapeutics is not publicly available.
Can I buy Endogena Therapeutics stock?
Endogena Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Endogena Therapeutics's last funding round?
Endogena Therapeutics's most recent funding round was Series A Extension on December 13, 2021.
Who are the main investors in Endogena Therapeutics?
Key investors in Endogena Therapeutics include DEFTA Partners.
Will Endogena Therapeutics IPO soon?
No public IPO plans have been announced for Endogena Therapeutics.
How can I track Endogena Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endogena Therapeutics's secondary market activity and sign up for updates.